Skip to main content
Have a personal or library account? Click to login
Assessing the role of serum Pentraxin-3 (PTX3) levels in hypothyroidism patients as risk marker of insulin resistance Cover

Assessing the role of serum Pentraxin-3 (PTX3) levels in hypothyroidism patients as risk marker of insulin resistance

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 3 (September 2023)
By: ,  ,   and    
Open Access
|Sep 2023
Authors

Authors

Israa Jafar

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq

Hanaa Addai Ali

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq

Rawaa Adday Ali

Department of Microbiology, College of Veterinary Medicine, Al-Qasim Green University, Babylon, Iraq

Mohauman Mohammed Al-Rufaie

muhaimin.alrufaie@uokufa.edu.iq

Department of Chemistry, Faculty of Science, University of Kufa, Najaf, Iraq
DOI: https://doi.org/10.2478/cipms-2023-0030 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 174 - 179
Submitted on: May 26, 2023
Accepted on: Jun 15, 2023
Published online: Sep 28, 2023
Published in print: Sep 1, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Keywords:
serum PTX3 levels,
hypothyroidism,
subclinical hypothyroidism,
thyroid hormone levels and TSH levels
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2023 Israa Jafar, Hanaa Addai Ali, Rawaa Adday Ali, Mohauman Mohammed Al-Rufaie, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 36 (2023): Issue 3 (September 2023)
Previous article
Next article